Literature DB >> 7168524

[Enzymatic typing of 11 strains of Leishmania isolated in mainland Italy from the visceral murine, canine and vulpine forms. Demonstration of an enzymatic variant in the fox (Vulpes vulpes) and the dog].

M Gramiccia, R Maazoun, G Lanotte, J A Rioux, S le Blancq, D A Evans, W Peters, S Bettini, L Gradoni, E Pozio.   

Abstract

Enzyme typing by starch gel electrophoretic techniques was carried out on 11 Leishmania isolates from Italy in laboratories in Montpellier and London. The enzymes studied in the former were ME, G-6-PD, 6-PGD, PGM, PGI, GOT (= ASAT), MDH and IDH. In London slightly different procedures were used to examine ME, 6-PGD, PGM, PGI and ASAT. In addition, SOD, ALAT, NH, and MPI were studied. The combined data revealed that four Rattus rattus and four dogs were infected with classical L. infantum (zymodème 1). In addition, two other dogs and a fox were infected with an enzyme variant (zymodème 18) which differed in four of the 12 enzymes examined. These findings raise the question of the heterogeneity of the parasites causing visceral leishmaniasis.

Entities:  

Mesh:

Year:  1982        PMID: 7168524

Source DB:  PubMed          Journal:  Ann Parasitol Hum Comp        ISSN: 0003-4150


  3 in total

1.  Leishmania infantum in wild rodents: reservoirs or just irrelevant incidental hosts?

Authors:  H M Navea-Pérez; V Díaz-Sáez; V Corpas-López; G Merino-Espinosa; F Morillas-Márquez; J Martín-Sánchez
Journal:  Parasitol Res       Date:  2015-03-24       Impact factor: 2.289

Review 2.  Role of wildlife in the epidemiology of Leishmania infantum infection in Europe.

Authors:  Javier Millán; Ezio Ferroglio; Laia Solano-Gallego
Journal:  Parasitol Res       Date:  2014-05-08       Impact factor: 2.289

3.  IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis.

Authors:  Pedro J Alcolea; Ana Alonso; Adriana Esteban; Paz Peris; Alberto Cortés; Juan A Castillo; Vicente Larraga
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.